Clark Hill: Cannabis Reclassification: Litigation Impact
May 6, 2024 Author Joshua Trombley In a historic move, the DEA accepted the US Department of Health and Human Services’ recommendation to reclassify marijuana from Schedule I to a Schedule III controlled substance, arguably the most significant change to federal drug...
Epstein Becker Green: Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies?
Lisa Gora, Natalie Moszczynski Epstein Becker & Green A major update in cannabis law was announced by the Drug Enforcement Administration (DEA) and Attorney General (AG) this past Tuesday, April 30, 2024 regarding their intent to ease restrictions on cannabis. The...
Hinshaw: DEA’s Decision to Reschedule Marijuana Represents a Massive Shift in U.S. Drug Policy, But Challenges for Cannabis Industry Remain
May 2, 2024 Hinshaw Alert https://www.hinshawlaw.com/newsroom-updates-hinshaw-alert-reschedule-marijuana-drug-enforcement-administration-decision.html Earlier this week, we learned that the United States Drug Enforcement Administration (DEA) will likely reclassify...
Miller Nash LLP: Cannabis & Taxes: Making Cents of Refunds and Reclassification
Justin Hobson Miller Nash LLP On April 30, 2024, the Associated Press announced the U.S. Drug Enforcement Agency (DEA) will move to reclassify cannabis from a Schedule I to Schedule III under the Controlled Substances Act. It is important to note that the move...
Clark Hill: Marijuana Rescheduling’s Impact on U.S. Customs and Border Patrol Interdiction of Drug Paraphernalia
May 2, 2024 R. Kevin Williams The Biden administration has proposed to reschedule marijuana from a Schedule I to Schedule III controlled substance. This reclassification will place marijuana in the same schedule as prescription drugs such as ketamine and Tylenol with...Top 200 Cannabis Lawyers
We Support